Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,106 public trials 2,040 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Ruxolitinib Phosphate to Treat Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma After Stem Cell Transplant

NCT01431209

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +13 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

Mayo Clinic Rochester, Minnesota, United States

University of Nebraska Medical Center Omaha, Nebraska, United States

View Trial Details

Completed

Sarilumab in Patients With Glucocorticoid-Dependent Sarcoidosis

NCT04008069

Conditions: Hemic and Lymphatic Diseases, Hypersensitivity, Hypersensitivity, Delayed, +4 more
Locations: Stanford University Palo Alto, California, United States

View Trial Details

Completed

Study of Lenalidomide and Ofatumumab for the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT01060384

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Saint Francis Medical Center Grand Island, Nebraska, United States

University of Nebraska Medical Center Omaha, Nebraska, United States

View Trial Details

Completed

Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

NCT01142427

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

USA Health Strada Patient Care Center Mobile, Alabama, United States

Providence Alaska Medical Center Anchorage, Alaska, United States

View all 244 locations

View Trial Details

Completed

Panobinostat and Carfilzomib in Treating Participants With Relapsed or Refractory Multiple Myeloma

NCT01301807

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Electrophysiological Biomarkers of Chemotherapy-related Cognitive Impairment and Recovery

NCT02767388

Conditions: Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +42 more
Locations: University of Nebraska Medical Center Omaha, Nebraska, United States

View Trial Details

Completed

LSA4 Protocol for the Treatment of Advanced Pediatric and Adolescent Non-Hodgkins Lymphoma

NCT00610883

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

A Safety and Effectiveness Study of Vaccine Therapy in Patients With Indolent Lymphoma

NCT00081809

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +27 more
Locations: M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma

NCT00574496

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +10 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

VELCADE®-BEAM and Autologous Hematopoietic Stem Cell Transplantation for Non-Hodgkin's Lymphoma, or Mantle Cell Lymphoma

NCT00571493

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: University of Nebraska Medical Center Omaha, Nebraska, United States

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions